Iron Dextran

Overview

4.1 out of 5 (8 Reviews)

Credits

1.00

Post Assessment Questions

6

Start Date

1 Sep 2023

Last Review Date

15 Feb 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6820 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 8101.5 hours of CE.

Single Activity

Take this single activity

$29 1 activity

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$89 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$139 per 1 year per user
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Iron dextran is an injectable complex comprising ferric hydroxide and a low-molecular-weight fraction of dextran. Iron dextran is an intravenous iron solution tailored to treat iron deficiency anemia. Oral iron therapy is frequently used for the treatment of iron deficiency anemia. However, certain patients either exhibit inadequate responses to oral iron or encounter difficulties in its administration. Iron dextran has been approved by the US Food and Drug Administration (FDA) for treating iron deficiency anemia in patients who are unresponsive to oral iron therapy or cannot tolerate it.

Injectable iron proves particularly beneficial in cases of iron deficiency stemming from conditions such as excessive iron loss (eg, hereditary hemorrhagic telangiectasia and significant blood loss) or iron malabsorption (eg, Crohn disease, celiac disease, inflammatory bowel disease, and gastric bypass). The appropriate application of iron dextran is recommended for iron deficiency anemia associated with menometrorrhagia, pregnancy, and surgical blood loss. This activity is tailored for healthcare professionals and summarizes indications, mechanisms of action, pharmacokinetics, administration protocols, and potential adverse effects associated with iron dextran therapy, emphasizing the pivotal role of an interprofessional healthcare team in optimizing patient outcomes while utilizing iron dextran. In addition, this activity highlights algorithms for making informed decisions in the clinical management of patients undergoing iron dextran treatment by providing insights into contraindications, monitoring strategies, and potential overdose risks of iron dextran.


UAN: JA4008338-0000-23-2492-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify appropriate candidates for iron dextran therapy based on their response to oral iron therapy, clinical indications, and iron deficiency anemia severity.

  • Screen patients for conditions that may benefit from iron dextran therapy, including those with excessive iron loss or malabsorption syndromes.

  • Assess patients for contraindications and potential adverse effects associated with iron dextran therapy, ensuring timely intervention if complications arise.

  • Collaborate with other healthcare professionals to optimize patient outcomes through coordinated care and shared decision-making.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.00 ACPE credit(s). (UAN: JA4008338-0000-23-2492-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Deborah Z. on 5/12/2021

Sunitha P. on 1/5/2022

Sheila F. on 8/10/2022

Heather D. on 1/26/2023

Bellamy B. on 10/13/2023

Michael L. on 10/26/2023

Andrew F. on 11/27/2023

Fariborz M. on 3/7/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6820 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 8101.5 hours of CE.

Single Activity

Take this single activity

$29 1 activity

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$89 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$139 per 1 year per user